Pascal Deschatelets, the Chief Scientific Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a biopharmaceutical company with a market capitalization of $3.9 billion and currently trading near ...
MALVERN, Pa., Jan. 17, 2025 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) announced today that Joel Keaton, ChiefOperatingOfficer, will retire effective April 30, 2025. In connection with Mr ...